Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    NITROFURANTOIN MACROCRYSTALLINE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 337Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 8, 2025
    Enforcement Report - Week of January 8, 2025

    08 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-8-2025-53657.pdf

    FDA
    08 Jan 2025
    Share Share
    CNX Therapeutics and Adalvo Announce Nitrofurantoin PR Agreement
    CNX Therapeutics and Adalvo Announce Nitrofurantoin PR Agreement

    16 Dec 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-12-16/cnx-therapeutics-and-adalvo-announce-strategic-agreement-for-commercialisation-of-nitrofurantoin-pr

    PHARMAWEB
    16 Dec 2024
    Share Share
    Enforcement Report - Week of July 24, 2024
    Enforcement Report - Week of July 24, 2024

    24 Jul 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-24-2024-12306.pdf

    FDA
    24 Jul 2024
    Share Share
    Omsav Pharma's Generic Nitrofurantoin Receives Approval in the U.S.
    Omsav Pharma's Generic Nitrofurantoin Receives Approval in the U.S.

    03 Nov 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217073

    FDA
    03 Nov 2023
    Share Share
    Mankind's Generic Nitrofurantoin Receives Approval in the U.S.
    Mankind's Generic Nitrofurantoin Receives Approval in the U.S.

    11 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217357

    FDA
    11 Jul 2023
    Share Share
    Aurobindo's Generic Nitrofurantoin Receives Receives Approval in the U.S.
    Aurobindo's Generic Nitrofurantoin Receives Receives Approval in the U.S.

    11 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212607

    FDA
    11 May 2023
    Share Share